본문 바로가기 주메뉴 바로가기
국회도서관 홈으로 정보검색 소장정보 검색

초록보기

Background: Voglibose is an α-glucosidase inhibitor. The purpose of this study was to evaluate the pharmacodynamic characteristics of voglibose for determining the appropriate study design and parameters for a pharmacodynamic equivalence study of voglibose.

Methods: This study consisted of two studies. The single dose study had an open and single sequence design. Nineteen subjects received placebo and then one tablet of voglibose on two consecutive days with sucrose. The multiple dose study was performed with the similar design, except that it was a multiple dose of the single dose study. Nine subjects who showed an effective response in the single dose study received placebo three times and then voglibose 4 times on two consecutive days. Serial blood samples for pharmacodynamic parameters were taken until 180 mins after each administration. The baseline adjusted maximum serum glucose level (Gmax) and area under the serum glucose level-time profiles were determined and compared.

Results: In the single dose study, the difference in Gmax was -10.6 ± 28.7 mg/dL. The area under the serum glucose concentration-time curve (AUGC0-1h) of placebo and voglibose were 7825.0 ± 1145.3 mg.min/dL, 7907.5 ± 917.2 mg.min/dL, respectively. In the multiple dose study, the difference in Gmax was 46.6 ± 16.1 mg/dL. The AUGC0-1h of placebo and voglibose were 8138.6 ± 721.9 mg.min/dL and 6499.7 ± 447.2 mg.min/dL, respectively. The Gmax and AUGC0-1h of the multiple dose study was significantly different between placebo and voglibose in paired t-test.

Conclusion: The differences in Gmax and AUGC0-1h are suitable for pharmacodynamic parameters to evaluate bioequivalence of voglibose.

참고문헌 (16건) : 자료제공( 네이버학술정보 )

참고문헌 목록에 대한 테이블로 번호, 참고문헌, 국회도서관 소장유무로 구성되어 있습니다.
번호 참고문헌 국회도서관 소장유무
1 The present state of diabetes mellitus in Korea 소장
2 Monnier, L., Is postprandial glucose a neglected cardiovascular risk factor in type 2 diabetes? Eur J Clin Invest, 2000;30(2):3-11. 미소장
3 [alpha-Glucosidase inhibitor]. 네이버 미소장
4 Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance 네이버 미소장
5 KFDA, KFDA web sites on Bioequivalence test information.http://drug.mfds.go.kr/html/men uLinkBody.jsp?p_menuId=0201#1. [Online] (last visited 01 May 2013). 미소장
6 Pharmacokinetics of acarbose. Part I: Absorption, concentration in plasma, metabolism and excretion after single administration of [14C]acarbose to rats, dogs and man. 네이버 미소장
7 The alpha-glucosidase inhibitor voglibose (AO-128) does not change pharmacodynamics or pharmacokinetics of warfarin. 네이버 미소장
8 Food and Drug Administration, Center of Drug Evaluation and Research (CDER), Guidance for Industry: Bioavailability and Bioequivalence Studies for Orally Administered Drug Products – General Considerations, 2003. 미소장
9 Food and Drug Administration, Center of Drug Evaluation and Research (CDER), Draft Guidance on Acarbose. 2009. 미소장
10 Methods for Pharmacodynamic Analysis and Proposed Protocols for Bioequivalence Study of Acarbose 소장
11 Min Zhang, Jin Yang, Lei Tao, Lingjun Li, Pengcheng Ma, John Paul Fawcett. Acarbose Bioequivalence: Exploration of New Pharmaco- dynamic Parameters. AAPS J, 2012;14(2):345- 351. 미소장
12 Pharmacodynamic comparison of two formulations of Acarbose 100-mg tablets. 네이버 미소장
13 Kageyama S, Nakamichi N, Sekino H, Nakano S. Comparison of the effects of acarbose and voglibose in healthy subjects. Clin Thera, 1997;19(4):720-729. 미소장
14 Comparison of the effects of acarbose and voglibose on plasma glucose, endogenous insulin sparing, and gastrointestinal adverse events in obese subjects: a randomized, placebo-controlled, double-blind, three-way crossover study 네이버 미소장
15 Food and Drug Administration, Center of Drug Evaluation and Research (CDER), Guidance for Industry: Diabetes Mellitus: Developing Drugs and Therapeutic Biologics for Treatment and Prevention (Draft). 2008. 미소장
16 Practical Diabetes Care. By David Levy. 3rd Edition Published by Wiley-Blackwell, 2011 Paperback, price: ISBN: 978 1 4443 3385 5 Website 네이버 미소장